DNA Replication Fork: Pausing, Recombination and Disease

DNA 复制叉:暂停、重组和疾病

基本信息

  • 批准号:
    6576325
  • 负责人:
  • 金额:
    $ 30.63万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2003
  • 资助国家:
    美国
  • 起止时间:
    2003-05-01 至 2008-02-28
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Patients with tuberous sclerosis complex and autosomal dominant polycystic kidney disease most often are born with anatomically normal kidneys but develop significant renal involvement as they age. The abnormal tissues in these diseases are associated with the loss of heterozygosity (LOH) such that only the defective allele is present at the disease locus. Although both diseases have a second associated gene, the TSC2 and PKD1 genes cause a more severe phenotype and are more often found in patients with new mutations. We postulate that the disease severity is related to the fact that these adjacent genes are in an unstable region of chromosome 16. We present evidence that inverted Alu repeats and polypurine.polypyrimidine tracts from these genes appear to be associated with deletions, and block the human replication fork. In addition, the polypurine.polypyrimidine tract, under conditions that favor alternative secondary structure formation, can spontaneously initiate replication. Such replication initiation and termination phenomenon have both developmental and mutagenic implications. The ultimate goal of our reseach is to retard disease onset and progression by delaying the second somatic mutation leading to the LOH in the TSC2 and PKD1 genes. We hypothesize that alternative DNA secondary structures in the TSC2 and PKD1 genes promote mutagenesis through their effects on DNA replication. The proposed studies investigate the DNA structural characteristics of the Pu.Py tracts and inverted Alu repeats using 2-dimensional gel and melting curve analyses. Using repair deficient cell lines, we will also determine the replication proteins involved. Using a stable-transfection system, we will measure the ability of the sequences to stall replication and to induce recombination. The potential to initiate the human replication fork will also be studied in a well characterized system. By understanding the effects of these sequences on the fidelity of DNA replication, therapeutic inroads into delaying disease onset can be made.
描述(由申请人提供):结节性硬化症和常染色体显性多囊肾病患者通常出生时肾脏解剖正常,但随着年龄的增长,肾脏受累严重。这些疾病中的异常组织与杂合性缺失(洛)相关,使得在疾病基因座处仅存在缺陷等位基因。虽然这两种疾病都有第二个相关基因,但TSC2和PKD1基因导致更严重的表型,并且更常见于新突变的患者。我们假设疾病的严重程度与这些相邻基因位于16号染色体的不稳定区域有关。我们提出的证据表明,从这些基因的反向Alu重复序列和聚嘌呤。聚嘧啶束似乎与缺失,并阻止人类复制叉。此外,多嘌呤、多嘧啶段在有利于形成替代性二级结构的条件下,可以自发地启动复制。这种复制起始和终止现象具有发育和致突变的意义。 本研究的最终目的是通过延缓TSC 2和PKD 1基因中导致洛缺失的第二个体细胞突变来延缓疾病的发生和发展。我们推测,替代的DNA二级结构中的TSC 2和PKD 1基因通过其对DNA复制的影响促进诱变。本研究利用二维凝胶和熔解曲线分析研究了Pu.Py片段和反向Alu重复序列的DNA结构特征。使用修复缺陷细胞系,我们还将确定涉及的复制蛋白。使用稳定转染系统,我们将测量序列停止复制和诱导重组的能力。还将在充分表征的系统中研究启动人类复制叉的潜力。通过了解这些序列对DNA复制保真度的影响,可以在延迟疾病发作方面取得治疗进展。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JOHN J BISSLER其他文献

JOHN J BISSLER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JOHN J BISSLER', 18)}}的其他基金

RAPAMYCIN THERAPY OF RENAL ANGIOMYOLIPOMAS
雷帕霉素治疗肾血管平滑肌脂肪瘤
  • 批准号:
    7607742
  • 财政年份:
    2007
  • 资助金额:
    $ 30.63万
  • 项目类别:
RAD001 THERAPY OF ANGIOMYOLIPOMATA IN PATIENTS WITH TSC
RAD001 血管平滑肌脂肪瘤治疗 TSC 患者
  • 批准号:
    7607778
  • 财政年份:
    2007
  • 资助金额:
    $ 30.63万
  • 项目类别:
RAPAMYCIN THERAPY OF RENAL ANGIOMYOLIPOMAS
雷帕霉素治疗肾血管平滑肌脂肪瘤
  • 批准号:
    7374516
  • 财政年份:
    2005
  • 资助金额:
    $ 30.63万
  • 项目类别:
RAD001 THERAPY OF ANGIOMYOLIPOMATA IN PATIENTS WITH TSC
RAD001 血管平滑肌脂肪瘤治疗 TSC 患者
  • 批准号:
    7374557
  • 财政年份:
    2005
  • 资助金额:
    $ 30.63万
  • 项目类别:
RAPAMYCIN THERAPY OF RENAL ANGIOMYOLIPOMAS
雷帕霉素治疗肾血管平滑肌脂肪瘤
  • 批准号:
    7203768
  • 财政年份:
    2004
  • 资助金额:
    $ 30.63万
  • 项目类别:
DNA Replication Fork: Pausing, Recombination and Disease
DNA 复制叉:暂停、重组和疾病
  • 批准号:
    6740173
  • 财政年份:
    2003
  • 资助金额:
    $ 30.63万
  • 项目类别:
Rapamycin Therapy of Renal Angiomyolipomas
雷帕霉素治疗肾血管平滑肌脂肪瘤
  • 批准号:
    7044210
  • 财政年份:
    2003
  • 资助金额:
    $ 30.63万
  • 项目类别:
DNA Replication Fork: Pausing, Recombination and Disease
DNA 复制叉:暂停、重组和疾病
  • 批准号:
    6859415
  • 财政年份:
    2003
  • 资助金额:
    $ 30.63万
  • 项目类别:
DNA Replication Fork: Pausing, Recombination and Disease
DNA 复制叉:暂停、重组和疾病
  • 批准号:
    7194967
  • 财政年份:
    2003
  • 资助金额:
    $ 30.63万
  • 项目类别:
DNA Replication Fork: Pausing, Recombination and Disease
DNA 复制叉:暂停、重组和疾病
  • 批准号:
    7030211
  • 财政年份:
    2003
  • 资助金额:
    $ 30.63万
  • 项目类别:

相似海外基金

Elucidation of the life-sustaining mechanism of hyperthermophilic archaea without DNA replication origin
阐明无DNA复制起点的超嗜热古菌的生命维持机制
  • 批准号:
    19K22289
  • 财政年份:
    2019
  • 资助金额:
    $ 30.63万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Identification of the DNA replication origin in Arabidopsis
拟南芥DNA复制起点的鉴定
  • 批准号:
    17K19250
  • 财政年份:
    2017
  • 资助金额:
    $ 30.63万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
Genome-wide identification of DNA replication origin sequences in human cells
人类细胞 DNA 复制起点序列的全基因组鉴定
  • 批准号:
    16K12595
  • 财政年份:
    2016
  • 资助金额:
    $ 30.63万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Linking DNA Replication Origin Licensing with Cell Cycle Progression
将 DNA 复制起点许可与细胞周期进展联系起来
  • 批准号:
    8457662
  • 财政年份:
    2013
  • 资助金额:
    $ 30.63万
  • 项目类别:
Integrating stress MAP kinase signaling with DNA replication origin licensing
将应激 MAP 激酶信号传导与 DNA 复制起点许可相结合
  • 批准号:
    8706908
  • 财政年份:
    2013
  • 资助金额:
    $ 30.63万
  • 项目类别:
Linking DNA Replication Origin Licensing with Cell Cycle Progression
将 DNA 复制起点许可与细胞周期进展联系起来
  • 批准号:
    8665806
  • 财政年份:
    2013
  • 资助金额:
    $ 30.63万
  • 项目类别:
Integrating stress MAP kinase signaling with DNA replication origin licensing
将应激 MAP 激酶信号传导与 DNA 复制起点许可相结合
  • 批准号:
    8824650
  • 财政年份:
    2013
  • 资助金额:
    $ 30.63万
  • 项目类别:
Linking DNA Replication Origin Licensing with Cell Cycle Progression
将 DNA 复制起点许可与细胞周期进展联系起来
  • 批准号:
    8829782
  • 财政年份:
    2013
  • 资助金额:
    $ 30.63万
  • 项目类别:
Diversity Supplement: Post-Translational Regulation of DNA Replication Origin Licensing in Human Cells
多样性补充:人类细胞中 DNA 复制起点许可的翻译后调控
  • 批准号:
    10120875
  • 财政年份:
    2013
  • 资助金额:
    $ 30.63万
  • 项目类别:
Post-translational regulation of DNA replication origin licensing in human cells
人类细胞 DNA 复制起点许可的翻译后调控
  • 批准号:
    10093060
  • 财政年份:
    2013
  • 资助金额:
    $ 30.63万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了